GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Amedisys Inc (AMED) [hlAlert]

Rating:
Mkt Outperform
AMED
down 37.05 %

Amedisys Inc (AMED) rated Mkt Outperform with price target $66 by Avondale

Posted on: Friday,  Jul 18, 2008  12:25 PM ET by Avondale

Avondale rated Mkt Outperform Amedisys Inc (NASDAQ: AMED) on 07/18/2008, when the stock price was $61.93. Since
then, Amedisys Inc has lost 37.06% as of 01/19/2016's recent price of $38.98.
If you would have followed this Avondale's recommendation on AMED, you would have lost 37.05% of your investment in 2741 days.

Amedisys, Inc. (Amedisys) is a provider of home health services to the chronic, co-morbid, aging American population. The services that the Company provides include both home health and hospice services with approximately 87% of its revenue derived from Medicare. As of December 31, 2008, Amedisys owned and operated 480 Medicare-certified home health agencies, 48 Medicare-certified hospice agencies and managed the operations of four Medicare-certified home health and two Medicare-certified hospice agencies in 37 states within the United States, the District of Columbia and Puerto Rico. Its home health patient is Medicare eligible, approximately years old and takes approximately 12 different medications on a daily basis and has multiple co-morbidities. For the Company?s home health patients, it receives a 60-day, episodic-based payment from Medicare. On March 26, 2008, the Company completed the acquisition of TLC Health Care Services, Inc.

Avondale’s research analysts are charged with producing high quality, independent, value-added, and timely investment analysis / advice. The firm’s strategy is to deemphasize maintenance research, and instead direct the overwhelming majority of our efforts on developing well-constructed, actionable recommendations, in part by leveraging proprietary networks of industry contacts. Avondale’s growing research department now totals 25 professionals. Senior analysts average 14 years of industry experience and are routinely recognized by a variety of nationally known rating entities. In the last two years, Avondale Analysts were named to the Wall Street Journal’s Best on the Street poll as well as Forbes.com’s Top Analyst Rankings.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/18/2008 12:25 PM Buy
None
61.93 66.00
as of 12/24/2008
1 Week down  -4.85 %
1 Month up  5.03 %
3 Months down  -33.10 %
1 YTD down  -30.30 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy